BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 8917582)

  • 1. Functional breakdown of the lipid bilayer of the myelin membrane in central and peripheral nervous system by disrupted galactocerebroside synthesis.
    Bosio A; Binczek E; Stoffel W
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13280-5. PubMed ID: 8917582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galactosphingolipids and axono-glial interaction in myelin of the central nervous system.
    Bosio A; Büssow H; Adam J; Stoffel W
    Cell Tissue Res; 1998 May; 292(2):199-210. PubMed ID: 9560463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability.
    Coetzee T; Fujita N; Dupree J; Shi R; Blight A; Suzuki K; Suzuki K; Popko B
    Cell; 1996 Jul; 86(2):209-19. PubMed ID: 8706126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Composition and biophysical properties of myelin lipid define the neurological defects in galactocerebroside- and sulfatide-deficient mice.
    Bosio A; Binczek E; Haupt WF; Stoffel W
    J Neurochem; 1998 Jan; 70(1):308-15. PubMed ID: 9422376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelin abnormalities in mice deficient in galactocerebroside and sulfatide.
    Dupree JL; Coetzee T; Suzuki K; Popko B
    J Neurocytol; 1998 Sep; 27(9):649-59. PubMed ID: 10447239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelin galactolipids are essential for proper node of Ranvier formation in the CNS.
    Dupree JL; Coetzee T; Blight A; Suzuki K; Popko B
    J Neurosci; 1998 Mar; 18(5):1642-9. PubMed ID: 9464989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myelin glycolipids and their functions.
    Stoffel W; Bosio A
    Curr Opin Neurobiol; 1997 Oct; 7(5):654-61. PubMed ID: 9384539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demyelination and altered expression of myelin-associated glycoprotein isoforms in the central nervous system of galactolipid-deficient mice.
    Coetzee T; Dupree JL; Popko B
    J Neurosci Res; 1998 Dec; 54(5):613-22. PubMed ID: 9843152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic analysis of myelin galactolipid function.
    Popko B; Dupree JL; Coetzee T; Suzuki K; Suzuki K
    Adv Exp Med Biol; 1999; 468():237-44. PubMed ID: 10635033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of galactolipid elimination on oligodendrocyte development and myelination.
    Marcus J; Dupree JL; Popko B
    Glia; 2000 Jun; 30(4):319-28. PubMed ID: 10797612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligodendrocyte-specific ceramide galactosyltransferase (CGT) expression phenotypically rescues CGT-deficient mice and demonstrates that CGT activity does not limit brain galactosylceramide level.
    Zöller I; Büssow H; Gieselmann V; Eckhardt M
    Glia; 2005 Nov; 52(3):190-8. PubMed ID: 15968630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the ceramide galactosyltransferase gene during myelination of the mouse nervous system. Comparison with the genes encoding myelin basic proteins, choline kinase and CTP:phosphocholine cytidylyltransferase.
    Garbay B; Cassagne C
    Brain Res Dev Brain Res; 1994 Nov; 83(1):119-24. PubMed ID: 7535200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neuronal adhesion protein TAG-1 is expressed by Schwann cells and oligodendrocytes and is localized to the juxtaparanodal region of myelinated fibers.
    Traka M; Dupree JL; Popko B; Karagogeos D
    J Neurosci; 2002 Apr; 22(8):3016-24. PubMed ID: 11943804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of non-hydroxy:alpha-hydroxy galactosylceramide ratio and unstable myelin in transgenic mice overexpressing UDP-galactose:ceramide galactosyltransferase.
    Fewou SN; Büssow H; Schaeren-Wiemers N; Vanier MT; Macklin WB; Gieselmann V; Eckhardt M
    J Neurochem; 2005 Jul; 94(2):469-81. PubMed ID: 15998297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nerve conduction velocity measurements reveal the functional deficit in ceramide galactosyl transferase-deficient (cgt-/-) mice.
    Haupt WF; Stoffel W
    J Neurol Sci; 2004 Jan; 217(1):83-8. PubMed ID: 14675614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of oligodendroglial glucosylceramide synthesis does not result in CNS myelin abnormalities or alter the dysmyelinating phenotype of CGT-deficient mice.
    Saadat L; Dupree JL; Kilkus J; Han X; Traka M; Proia RL; Dawson G; Popko B
    Glia; 2010 Mar; 58(4):391-8. PubMed ID: 19705459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The UDP-galactose:ceramide galactosyltransferase: expression pattern in oligodendrocytes and Schwann cells during myelination and substrate preference for hydroxyceramide.
    Schaeren-Wiemers N; van der Bijl P; Schwab ME
    J Neurochem; 1995 Nov; 65(5):2267-78. PubMed ID: 7595516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galactolipids in the formation and function of the myelin sheath.
    Dupree JL; Suzuki K; Popko B
    Microsc Res Tech; 1998 Jun; 41(5):431-40. PubMed ID: 9672425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic dissection of myelin galactolipid function.
    Dupree JL; Popko B
    J Neurocytol; 1999; 28(4-5):271-9. PubMed ID: 10739570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation, characterization, and expression of cDNA clones that encode rat UDP-galactose: ceramide galactosyltransferase.
    Stahl N; Jurevics H; Morell P; Suzuki K; Popko B
    J Neurosci Res; 1994 Jun; 38(2):234-42. PubMed ID: 7521399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.